Get started
Author

Joram Huckriede

Observed names: Huckriede, Joram, J. B. Huckriede, Joram B. Huckriede, Joram Bernd Huckriede, Joram P. Huckriede
Institution: Mayo Clinic
Observed institutions: Mayo Clinic, Maastricht University
ORCID: 0009-0004-7577-0154
Observed ORCID: 0009-0004-7577-0154
OpenAlex ID: A5068738004
The Anticoagulant and Nonanticoagulant Properties of Heparin
2020 · Danielle M. H. Beurskens, Joram P. Huckriede, et al. · Thrombosis and Haemostasis · 135
PDF
Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19
2020 · Matthias H. Busch, Sjoerd A.M.E.G. Timmermans, et al. · Circulation · 116
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
2021 · Joram Huckriede, Sara Bülow Anderberg, et al. · Scientific Reports · 86
PDF
Histone H3 Cleavage in Severe COVID-19 ICU Patients
2021 · Joram Huckriede, Femke de Vries, et al. · Frontiers in Cellular and Infection Microbiology · 48
PDF
The role of extracellular histones in COVID‐19
2022 · Femke de Vries, Joram Huckriede, et al. · Journal of Internal Medicine · 47
PDF
Multimodal measurement of glycocalyx degradation during coronary artery bypass grafting
2022 · Martine E. Bol, J. B. Huckriede, et al. · Frontiers in Medicine · 22
PDF
Design and characterization of novel activated protein C variants for the proteolysis of cytotoxic extracellular histone H3
2023 · Joram B. Huckriede, Daniëlle M.H. Beurskens, et al. · Journal of Thrombosis and Haemostasis · 18
PDF
Histon activities in the extracellular environment: regulation and prothrombotic implications
2024 · Gwen M. Keulen, Joram Huckriede, et al. · Current Opinion in Hematology · 13
Proteolytic neutralization of extracellular histones by neutrophil elastase is enhanced by heparin
2025 · Joram Huckriede, Gwen M. Keulen, et al. · Journal of Thrombosis and Haemostasis · 9
Markers of NETosis and DAMPs are altered in critically ill COVID-19 patients
2020 · Joram Huckriede, Sara Bülow Anderberg, et al. · 6
PDF
A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patients
2025 · Niels van Mourik, Rombout B. E. van Amstel, et al. · Intensive Care Medicine Experimental · 3
PDF
Association of corticosteroid therapy with reduced acute kidney injury and lower NET markers in severe COVID-19: an observational study
2024 · Sara Bülow Anderberg, Joram Huckriede, et al. · Intensive Care Medicine Experimental · 3
PDF
Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients
2022 · Rickard Lagedal, Oskar Eriksson, et al. · Journal of Clinical Medicine · 2
PDF
Characterization of myocardial immune cell infiltrates in desmoplakin cardiomyopathy: Insights from explanted hearts
2026 · Fatima M. Ezzeddine, Ke Zhang, et al. · Heart Rhythm O2
PDF
Abstract Wed097: Endothelial CD40 Facilitates Atherosclerosis Progression By Driving Endothelial-Mesenchymal Transition (EndMT)-Mediated Inflammation
2026 · Kim Dzobo, Katrin Nitz, et al. · Arteriosclerosis Thrombosis and Vascular Biology
Abstract Or114: V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is protective against atherosclerosis
2026 · Sachi Chaudhari, Katrin Nitz, et al. · Arteriosclerosis Thrombosis and Vascular Biology
Extracellular histones as novel theranostic targets in severe infection and immunothrombosis
2025 · Joram Bernd Huckriede
PDF
Works count: 34
Citation count: 508
H-index: 9
I10-index: 8
Year
Topic
Type